Actuarial 2-Year Survival, DFS, Relapse Rate, and Transplant-Related Mortality of 79 Patients Transplanted in First CR With ABMT
| . | N . | Survival . | . | DFS . | . | Relapse . | . | TRM . | |
|---|---|---|---|---|---|---|---|---|---|
| Disease category | |||||||||
| MDS | 19 | 46% | 40% | 58% | 5% | ||||
| sAML | 39 | 34% | .68* | 30% | .61* | 68% | .60* | 5% | .77* |
| Postcytotoxic MDS or sAML | 21 | 41% | 36% | 60% | 10% | ||||
| Age (yr) | |||||||||
| <40 | 45 | 46% | 39% | 59% | 5% | ||||
| ≥40 | 34 | 27% | .09* | 25% | .04* | 72% | .05* | 9% | .46* |
| . | N . | Survival . | . | DFS . | . | Relapse . | . | TRM . | |
|---|---|---|---|---|---|---|---|---|---|
| Disease category | |||||||||
| MDS | 19 | 46% | 40% | 58% | 5% | ||||
| sAML | 39 | 34% | .68* | 30% | .61* | 68% | .60* | 5% | .77* |
| Postcytotoxic MDS or sAML | 21 | 41% | 36% | 60% | 10% | ||||
| Age (yr) | |||||||||
| <40 | 45 | 46% | 39% | 59% | 5% | ||||
| ≥40 | 34 | 27% | .09* | 25% | .04* | 72% | .05* | 9% | .46* |
Abbreviation: TRM, treatment-related mortality.
P value, log-rank test.